Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment

Por Vollmer, Brandi L., Nair, Kavita, Sillau, Stefan, Corboy, John R., Vollmer, Timothy, Alvarez, Enrique
Publicado no Ann Clin Transl Neurol (2020)

Differences in healthcare visit frequency and type one year prior to stroke among young versus middle-aged adults

Por Vollmer, Brandi L., Chen, Xing, Kulick, Erin R., Elkind, Mitchell S. V., Boehme, Amelia K.
Publicado no BMC Health Serv Res (2021)

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment

Por Vollmer, Brandi L., Nair, Kavita V., Sillau, Stefan, Corboy, John R., Vollmer, Timothy, Alvarez, Enrique
Publicado no Ann Clin Transl Neurol (2018)

Serious safety events in rituximab‐treated multiple sclerosis and related disorders

Por Vollmer, Brandi L., Wallach, Asya I., Corboy, John R., Dubovskaya, Karolina, Alvarez, Enrique, Kister, Ilya
Publicado no Ann Clin Transl Neurol (2020)